Involvement of dysadherin and E-cadherin in the development of testicular tumours

British Journal of Cancer

Volumn 93, Issue 12, 2005, Pages 1382-1387

  Batistatou, A ^a   Scopa, C D ^b   Ravazoula, P ^b   Nakanishi, Y ^c   Peschos, D ^a   Agnantis, N J ^a   Hirohashi, S ^c   Charalabopoulos, K A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Dysadherin; E cadherin; Embryonal carcinoma; Lymphoma; Seminoma; Testicular tumours

Indexed keywords

CELL MEMBRANE PROTEIN; DYSADHERIN; UNCLASSIFIED DRUG; UVOMORULIN;

ADOLESCENT; ADULT; ANAPLASTIC CARCINOMA; ARTICLE; CANCER INVASION; CARCINOGENESIS; CARCINOMA IN SITU; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EMBRYONAL CARCINOMA; GERM CELL; GERM CELL TUMOR; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SEMINOMA; SOMATIC CELL; TERATOMA; TESTIS TUMOR; TUMOR CELL; VASCULARIZATION; YOLK SAC TUMOR;

ADOLESCENT; ADULT; AGED; CADHERINS; CARCINOMA, EMBRYONAL; CELL ADHESION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, NON-HODGKIN; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; TESTICULAR NEOPLASMS;

EID: 28644438821     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602880     Document Type: Article

References (28)

1. Adami HO, Bergstrom R, Mohner M, Zatonski W, Storm H, Ekbom A, Tretli S, Teppo L, Ziegler H, Rahu M (1994) Testicular cancer in nine northern European countries. Int J Cancer 59: 33-38
2. Aoki S, Shimamura T, Shibata T, Nakanishi Y, Moriya Y, Sato Y, Kitajima M, Sakamoto M, Hirohashi S (2003) Prognostic significance of dysadherin expression in advanced colorectal carcinoma. Br J Cancer 88: 726-732
3. Aubry F, Satie A-P, Rioux-Leclercq N, Rajpert-De Meyts E, Spagnoli GC, Chomez P, De Backer O, Jegou B, Samson M (2001) MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumors. Cancer 92: 2778-2785
4. Chang HW, Chow V, Lam KY, Wei WI, Yuen A (2002) Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Cancer 94: 386-392
5. Charalabopoulos K, Binolis J, Karkabounas S (2002) Adhesion molecules in carcinogenesis. Exp Oncol 24: 249-257
6. Charalabopoulos K, Gogali A, Kostoula OK, Constantopoulos H (2004) Cadherin superfamily of adhesion molecules in primary lung cancer. Exp Oncol 16: 256-260
7. Delgado R, Rathi A, Albores-Saavedra J, Gazdar AF (2000) Expression of the RNA component of human telomerase in adult testicular germ cell neoplasia. Cancer 86: 1802-1811
8. Heidenreich A, Sesterhenn IA, Mostofi FK, Moul JW (1998) Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer 83: 1002-1011
9. Hirohashi S, Kanai Y (2003) Cell adhesion system and human cancer morphogenesis. Cancer Sci 94: 575-581
10. Honecker F, Kersemaekers A-M F, Molier M, Van Weeren PC, Stoop H, De Krijger RR, Wolffenbuttel KP, Oosterhuis W, Bokemeyer C, Looijenga LH (2004) Involvement of E-cadherin and b-catenin in germ cell tumours and in normal male fetal germ cell development. J Pathol 204: 167-174
11. Ino Y, Gotoh M, Sakamoto M, Tsukagoshi K, Hirohashi S (2002) Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis. Proc Natl Acad Sci USA 99: 365-370
12. Kawakami T, Okamoto K, Kataoka A, Koizumi S, Iwaki H, Sugihara H, Reeve AE, Ogawa O, Okada Y (2003) Multipoint methylation analysis indicates a distinctive epigenetic phenotype among testicular germ cell tumors and testicular malignant lymphomas. Genes, Chromosomes Cancer 38: 97-101
13. Massarelli E, Brown E, Tran NK, Liu DD, Izzo JG, Lee JJ, El-Naggar AK, Hong WK, Papadimitrakopoulou VA (2005) Loss of E-cadherin and p27 expression is associated with head and neck squamous tumorigenesis. Cancer 103: 952-959
14. Mostofi FK, Sobin LH (1997) Histological typing of testis tumours: International classification of tumors, vol 16. Geneva: World Health Organization
15. Nagar B, Overduin M, Ikura M, Rini JM (1996) Structural basis of calcium-induced E-cadherin rigidification and dimerization. Nature 380: 360-364
16. Nakanishi Y, Akimoto S, Sato Y, Kanai Y, Sakamoto M, Hirohashi S (2004) Prognostic significance of dysadherin expression in tongue cancer: immunohistochemical analysis of 91 cases. Appl Immunohistochem Mol Morphol 12: 323-328
17. Nishizawa A, Nakanishi Y, Yoshimura K, Sasajima Y, Yamazaki N, Yamamoto A, Hanada K, Kanai Y, Hirohashi S (2005) Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma. Cancer 103: 1693-1700
18. Rosai J (2004) Male reproductive system. In Rosai and Ackerman's Surgical Pathology 9th Edn. New York: Mosby-Elsevier Inc., pp 1417-1436
19. Saito T, Katagiri A, Watanabe R, Tanikawa T, Kawasaki T, Tomita Y, Takahashi K (2000) Expression of E-cadherin and catenins on testis tumor. Urol Int 65: 140-143
20. Sato H, Ino Y, Miura A, Abe Y, Sakai H, Ito K, Hirohashi S (2003) Dysadherin: expression and clinical significance in thyroid carcinoma. J Clin Endocrinol Metab 88: 4407-4412
21. Shimada Y, Hashimoto Y, Kan T, Kawamura J, Okumura T, Soma T, Kondo K, Teratani N, Watanabe G, Ino Y, Sakamoto M, Hirohashi S, Imamura M (2004a) Prognostic significance of dysadherin expression in esophageal squamous cell carcinoma. Oncology 67: 73-80
22. Shimada Y, Yamasaki S, Hashimoto Y, Ito T, Kawamura J, Soma T, Ino Y, Nakanishi Y, Sakamoto M, Hirohashi S, Imamura M (2004b) Clinical significance of dysadherin expression in gastric cancer patients. Clin Cancer Res 10: 2818-2823
23. Shimamura T, Sakamoto M, Ino Y, Sato Y, Shimada K, Kosuge T, Sekihara H, Hirohashi S (2003) Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to E-cadherin expression. J Clin Oncol 21: 459-467
24. Shimamura T, Yasuda J, Ino Y, Gotoh M, Tsuchiya A, Nakajima A, Sakamoto M, Kanai Y, Hirohashi S (2004) Dysadherin expression facilitates cell motility and metastatic potential of human pancreatic cancer cells. Cancer Res 64: 6989-6995
25. Takeichi M (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-1455
26. Tsuiji H, Takasaki S, Sakamoto M, Irimura T, Hirohashi S (2003) Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion. Glycobiology 13: 521-527
27. Wu D, Qiao Y, Kristensen GB, Li S, Li S, Troen G, Holm R, Nesland JM, Suo Z (2004) Prognostic significance of dysadherin expression in cervical squamous cell carcinoma. Pathol Oncol Res 10: 212-218
28. Zhang HK, Zhang QM, Zhao TH, Li YY, Yi YF (2004) Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance. World J Gastroenterol 10: 3044-3047